首页 > 市场调查报告书 > 製药

生技设备生物工艺

市场调查报告书

商品编码

1495572

生物过程分析仪市场 - 按产品、分析类型、应用、最终用途 - 全球预测

Bioprocess Analyzers Market - By Product, Analysis Type, Application, End-use - Global Forecast

出版日期: 2024年03月28日 | 出版商:

Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年至2032 年间，生物製程分析仪市场规模的复合年增长率将达到15.2%。对生物製程分析仪的需求，以监测和优化生物製药生产过程。根据世界卫生组织的数据，2022 年，约有 2,000 万个新诊断癌症病例，死亡人数达 970 万人。在生物技术和个人化医疗进步的推动下，生物製药产业在全球范围内不断扩张，对先进分析工具的需求日益增长，以确保产品品质、一致性和法规遵循。

生物製程分析仪不断取得的技术进步，包括自动化、小型化和先进感测器技术的集成，提高了其效率、准确性和可靠性，推动了其在生物製药生产设施中的采用。这些先进的分析仪能够即时监测关键製程参数，例如细胞活力、代谢物浓度和产品滴度，促进製程优化并加速生物製药产品的上市时间。

生物製程分析仪产业分为产品、分析类型、应用、最终用途和地区

根据产品，到2032 年，仪器领域的市场价值预计将实现15.4% 的复合年增长率。分析仪器。分光光度计、色谱系统和质谱仪等仪器可以即时分析关键製程参数，以确保产品品质、一致性和法规遵循。

抗生素应用领域的生物过程分析仪市场预计在 2024 年至 2032 年期间将以 15.4% 的复合年增长率产生可观的收入。传染病和抗生素抗药性病原体的日益流行正在推动对新型抗生素和抗菌剂的需求，因此需要高效的生物工艺来生产它们。为此，生物製程分析仪有助于优化发酵和纯化过程，同时确保抗生素生产的品质、产量和一致性。

到2032 年，亚太地区生物製程分析仪市场规模将实现15.8% 的成长率。流程中的製程优化和品质控制。生物製程分析仪的快速技术进步，例如自动化、小型化和即时监控功能，以提高其效率和准确性，将进一步推动区域市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 对生物製药产品的需求不断增长
  - 生物技术和生物加工的进步
  - 对生物相似药的需求不断增加
  - 政府措施和资金不断增加
- 产业陷阱与挑战
  - 仪器成本高
  - 复杂性和技术专长
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
仪器
耗材及配件

第 6 章：市场估计与预测：按分析类型，2021 - 2032 年

主要趋势
底物分析
代谢物分析
含量检测

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
抗生素
重组蛋白
生物相似药
其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
生物製药公司
CRO 和 CMO
研究与学术机构
其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Agilent Technologies, Inc.
Algenax
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Groton Biosystems LLC
Kaiser Optical Systems, Inc.
Nova Biomedical
Randox Laboratories Ltd.
Sartorius AG
SYSBIOTECH GmbH
Thermo Fisher Scientific Inc.
YSI Inc.

简介目录

Product Code: 8765

Bioprocess analyzers market size will record 15.2% CAGR between 2024 and 2032. The increasing adoption of biopharmaceuticals for the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases is fueling the demand for bioprocess analyzers to monitor and optimize biopharmaceutical production processes. As per WHO, in 2022, approximately 20 million new cancer diagnoses were recorded, with fatalities reaching 9.7 million. As the biopharmaceutical industry continues to expand globally, driven by advancements in biotechnology and personalized medicine, there is a growing need for advanced analytical tools to ensure product quality, consistency, and regulatory compliance.

Rising technological advancements in bioprocess analyzers, including the integration of automation, miniaturization, and advanced sensor technologies, enhance their efficiency, accuracy, and reliability, driving their adoption across biopharmaceutical manufacturing facilities. These advanced analyzers enable real-time monitoring of critical process parameters, such as cell viability, metabolite concentrations, and product titers, facilitating process optimization and faster time-to-market for biopharmaceutical products.

The bioprocess analyzer industry is classified into product, analysis type, application, end use and region

Based on product, the market value from the instruments segment is expected to witness 15.4% CAGR through 2032. Rapid advancements in bioprocess technology and increasing demand for biopharmaceuticals are necessitating sophisticated analytical instruments capable of monitoring and optimizing complex bioprocessing workflows. Instruments, such as spectrophotometers, chromatography systems, and mass spectrometers, enable real-time analysis of critical process parameters for ensuring product quality, consistency, and regulatory compliance.

bioprocess analyzers market from the antibiotics application segment is slated to generate notable revenue at 15.4% CAGR during 2024-2032. The increasing prevalence of infectious diseases and antibiotic-resistant pathogens is driving the demand for novel antibiotics and antimicrobial agents, necessitating efficient bioprocesses for their production. To that end, bioprocess analyzers help in optimizing fermentation and purification processes while ensuring the quality, yield, and consistency of antibiotic production.

Asia Pacific bioprocess analyzers market size will record a 15.8% growth rate through 2032. The expanding biopharmaceutical sector, fueled by increasing demand for personalized medicine and biologics, is necessitating advanced analytical tools for process optimization and quality control in bioprocessing workflows. Rapid technological advancements in bioprocess analyzers, such as automation, miniaturization, and real-time monitoring capabilities to enhance their efficiency and accuracy will further drive the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing demand for biopharmaceutical products
  - 3.2.1.2 Advancements in biotechnology and bioprocessing
  - 3.2.1.3 Increasing demand for biosimilars
  - 3.2.1.4 Rising government initiatives and funding
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of instruments
  - 3.2.2.2 Complexity and technical expertise
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
5.3 Consumables & accessories

Chapter 6 Market Estimates and Forecast, By Analysis Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Substrate analysis
6.3 Metabolite analysis
6.4 Contentration detection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Antibiotics
7.3 Recombinant proteins
7.4 Biosimilars
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Biopharmaceutical companies
8.3 CROs & CMOs
8.4 Research & academic institutes
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa